+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Interspinous Spacers Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 4896246
  • Report
  • June 2020
  • Region: Global
  • 112 Pages
  • Mordor Intelligence


  • Boston Scientific
  • Globus Medical, Inc.
  • Johnson & Johnson
  • Life Spine, Inc.
  • Medtronic plc
  • Mikai S.p.A
The interspinous spacer is a small implant that is used to relieve the painful symptoms of spinal stenosis, which is a painful condition caused by a narrowing of the spinal canal. The spacer is an implant designed to keep the space between your spinous processes open, so that when you stand upright, the nerves in your back will not be pinched or cause pain. As the geriatric population is increasing globally and there is an increasing demand for minimally invasive procedures for spinal stenosis that has helped in the growth of this market. In addition, there are also increasing technological advancements seen in this field, therefore the demand for interspinous spacers is increasing.

However, compilations related to interspinous spacer, especially in the older population, have been restraining the overall growth of the market.

Key Market Trends

Lumbar Spinal Stenosis Segment is Expected to Dominate the Market

Lumbar spinal stenosis is a narrowing of the spinal canal, compressing the nerves traveling through the lower back into the legs. While it may affect younger patients, due to developmental causes, it is more often a degenerative condition that affects people who are typically age 60 and older.

The global geriatric population is increasing rapidly, especially in developed countries like the United States and Japan. According to a 2017 report by the United Nations, Japan was the world’s most aged population in 2017 with 33% of the population aged 60 or over. Moreover, and it is projected to remain so through 2050 with 42% of its population aged 60 or over.

As elderly population is more prone to lumbar spinal stenosis, the demand for interspinous spacers is expected to increase in the future, helping the market grow.

North America is Expected to Dominate the Interspinous Spacers Market

In United States, the percentage population above 60 years of age is expected to increase from 21.5% in 2017 to 27.8% in 2050, as per a 2017 United Nations report. Even Canada's popualation above 60 years of age or above is estimated to increase from 23.5% in 2017 to more than 32% in 2050. As aging population is more prone to spinal stenosis, the prevalence is expected to increase in these countries. However, the United States and Canada also has well developed healthcare systems and also spend huge amounts in research and development fo the same. As a result, most of the global treatments are available in this region. Hence all these factors have helped many global players to make their presence in this region. As a result, the market have grown, and is also expected to grow in future.

Competitive Landscape

Majority of the Interspinous Spacer products are being manufactured by the global key players. The major market players in this industry are engaged in intensive research and development programs to introduce the next generation of surgical solutions with improved safety and efficacy outcomes. These players are also focused on research & development of innovative solutions for spine surgeries, geographic expansion through collaboration and mergers, and new product launches to expand presence in the global market.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • Boston Scientific
  • Globus Medical, Inc.
  • Johnson & Johnson
  • Life Spine, Inc.
  • Medtronic plc
  • Mikai S.p.A

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Minimally Invasive Solutions
4.2.2 Increasing Geriatric Population
4.2.3 Growth in Research and Technological Advancements in Interspinous Spacers
4.3 Market Restraints
4.3.1 Complications associated with Lumbar Spinal Fusion
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type
5.1.1 Static (Non-compressible Spacers)
5.1.2 Dynamic (Compressible Spacers)
5.2 By Application
5.2.1 Lumbar Spinal Stenosis
5.2.2 Degenerative Disc Diseases
5.2.3 Others
5.3 By End-User
5.3.1 Hospitals and Clinics
5.3.2 Ambulatory Surgical Centers
5.3.3 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Zimmer Biomet
6.1.2 NuVasive, Inc.
6.1.3 Life Spine, Inc.
6.1.4 RTI Surgical Holdings, Inc. (Paradigm Spine LLC)
6.1.5 Boston Scientific
6.1.6 Johnson & Johnson
6.1.7 Globus Medical, Inc.
6.1.8 Mikai S.p.A
6.1.9 Medtronic plc
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Zimmer Biomet
  • NuVasive, Inc.
  • Life Spine, Inc.
  • RTI Surgical Holdings, Inc. (Paradigm Spine LLC)
  • Boston Scientific
  • Johnson & Johnson
  • Globus Medical, Inc.
  • Mikai S.p.A
  • Medtronic plc
Note: Product cover images may vary from those shown